Key facts
- Hedgehog MedTech’s last known valuation is $24.5M (Nov 2025).
- It has raised $7.9M; the latest was Early Stage VC ($3.5M) in Nov 2025.
- Notable investors include SMBC Venture Capital, DBJ Capital, Scrum Ventures, Mirai Cross, Keio Innovation Initiative — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Hedgehog MedTech
- ·The full record, as it builds
Funding rounds
No funding rounds for Hedgehog MedTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hedgehog MedTech
Operator of a health application intended to help with headache treatments. The company's application is a system that can reduce symptoms by recognizing and improving behavioral patterns and then providing treatment by conducting cognitive-behavioral therapy, which is effective in migraine treatment, through a smartphone app, enabling users to connect daily life and medical care.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2021
- Employees
- 5
- Website
- h-medtech.com/
- Ownership
- Privately Held (backing)
Hedgehog MedTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hedgehog MedTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hedgehog MedTech in its N-PORT filings yet. We sweep new filings monthly.